This week, we’re sharing the most recent top stories in psychiatry news.
Read more on these stories below.
OUD Overdose, Suicide Risk in Veterans Four Times Higher Without Buprenorphine American Psychiatric Association, Aug 24, 2021
“Veterans in particular may represent a unique population that has some additional challenges, including physical and mental trauma, chronic pain and injury, and higher rates of homelessness.”
Q&A: Determining the gut microbiome’s impact on psychiatric disorders Healio, Aug 25, 2021
Healio GI spoke with Sabine Hazan, MD, creator of ProgenaBiome and founder of Ventura clinical trials, about her recent research in the gut-brain connection and the role the gut microbiome plays in overall health.
FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia Medscape Medical News, Sept 1, 2021
This marks the “first-and-only twice-yearly injectable” approved for treating schizophrenia, the company announced in a press release.
FDA OKs IV Briviact for Seizures in Kids as Young as 1 Month Medscape Medical News, Aug 30, 2021
The US Food and Drug Administration (FDA) has expanded the indication for brivaracetam (Briviact, UCB) as both monotherapy or adjunctive therapy for partial-onset seizures in patients as young as 1 month of age.
Interventions needed for adolescents with pandemic-related anxieties Healio, Aug 24, 2021
“Emerging evidence suggests that there is a negative association between the pandemic and young people’s health and well-being, especially mental and social health (eg, depression, quality of life, loneliness) and physical activity”.